MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY-ASSOCIATED DISEASE

This adverse event was reported 154 times

These drugs are most commonly taken by patients reporting MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY-ASSOCIATED DISEASE:

# Drug Count
0 RITUXIMAB 29
1 ADALIMUMAB 25
2 ADALIMUMAB-AATY 24
3 ADALIMUMAB-ADAZ 23
4 ADALIMUMAB-FKJP 23
5 PEMBROLIZUMAB 13
6 PREDNISONE 12
7 INFLIXIMAB 11
8 MYCOPHENOLATE MOFETIL 11
9 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 11
See all common drugs associated with MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY-ASSOCIATED DISEASE

MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY-ASSOCIATED DISEASE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CETRORELIX ACETATE 3 0.0047
1 FOLLITROPIN ALFA 3 0.0015
2 MENOTROPINS 3 0.0014
3 BEDAQUILINE FUMARATE 1 0.0007
4 FINGOLIMOD HYDROCHLORIDE 3 0.0006
5 ADALIMUMAB-FKJP 23 0.0005
6 ADALIMUMAB-AATY 24 0.0005
7 PERPHENAZINE 1 0.0005
8 ADALIMUMAB-ADAZ 23 0.0004
9 CLADRIBINE 3 0.0003
See all drugs enriched for association with MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY-ASSOCIATED DISEASE